Discover investment opportunities in Stocks Under $1 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Stocks Under $1 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Stocks Under $1 using our Smart AI Filter.
6 stocks found for "Stocks Under $1"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
0.76 | ±100.0% | -0.1 | 0.00% | |||
1.01 | ±72.3% | -3.1 | 0.00% | |||
0.15 | ±100.0% | -0.2 | 0.00% | |||
0.65 | ±93.4% | -1.0 | 0.00% | |||
0.64 | ±100.0% | -0.4 | 0.00% | |||
1.11 | ±100.0% | — | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Oncolytics Biotech (ONCY) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Read moreDiscover why Zacks rates Healthcare Triangle as "Underperform", being the first on Wall Street to initiate coverage on the stock. Explore HCTI's heavy reliance on top clients amid liquidity issues and ongoing losses.
Read moreKaixin Auto Holdings (NASDAQ: KXIN) revealed that Beijing Camping Club Sports and Culture Communication Co Ltd (Camping Club) has agreed to order about 20,000 new energy vehicles over the next five years. The value of the order totals RMB6 billion ($938 million).
Read moreQ: What sector does REED belong to, and what are its potential investment appeals?
A: REED is in the beverage sector, specializing in natural and organic drinks. Some investors consider the growing consumer preference for health-conscious and sustainable products an appeal, with REED aligning well with these trends.
Q: How has SEAC performed historically in volatile markets?
A: Investors often examine SEAC's role in the advertising technology sector, which can exhibit volatility depending on digital ad spending trends. Historical performance in fluctuating markets may vary, requiring deeper analysis.
Q: What makes KXIN a unique investment in its industry?
A: KXIN operates in the automotive retail industry with a focus on used car sales, particularly in China. Its unique position in a large, evolving market could attract investors seeking exposure to international automotive growth.
Q: Which industry does VTAK operate in, and what risks should investors consider?
A: VTAK is involved in the biotechnology sector. Investors should consider risks such as regulatory approvals, clinical trial outcomes, and fluctuating healthcare policies, all of which could impact company performance.
Q: What economic factors might influence NUWE's financial health?
A: NUWE is part of the healthcare sector. Factors like public health spending, regulatory changes, and technology advancements could significantly impact its financial performance, though specific impacts would need further analysis.
Q: How does VXRT’s approach to innovation potentially create value for investors?
A: VXRT focuses on vaccine development with its oral tablet platform. This innovative approach could capture investor interest due to the potential ease of distribution and administration, especially during global health challenges.